Skip to content

A multicenter study on pulmonary rehabilitation in severe COVID-19 patients

A multicenter study on respiratory rehabilitation in severe COVID-19 patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043682
Enrollment
Unknown
Registered
2021-02-26
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) According to the COVID-19 diagnosis and treatment protocol (trial Seventh Edition), the patient was diagnosed as a critically ill patient of COVID-19 (severe / critical group); (2) The patient signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) the subjects did not follow the research scheme and had poor compliance; (2) the subjects voluntarily asked to withdraw; (3) the researchers believe that there are other situations in which the subjects are not suitable to participate in this study; (4) the researchers assessed that the subjects in the trial group had contraindications for pulmonary rehabilitation, such as: 1) patients with myocardial infarction and shock in recent 3 months; 2) patients with severe cardiac instability and angina pectoris in recent 4 weeks; 3) massive hemoptysis in recent 4 weeks; 4) epileptic seizures need to be treated with drugs; 5) patients with uncontrolled hypertension (systolic blood pressure > 200mmHg, diastolic blood pressure > 100mmHg); 6) patients with aortic aneurysm; 7) severe hyperthyroidism; 8) Heart rate > 120 beats / min; 9) pneumothorax, giant pulmonary vesicles and not ready for surgical treatment; 10) pregnant women; 11) patients with tympanic membrane perforation; 12) recent respiratory tract infection (< 4 weeks); 13) those with low immunity. Patients with respiratory infectious diseases (such as tuberculosis, influenza); 14) the researchers believe that there are other conditions in which patients are not suitable for respiratory rehabilitation.

Design outcomes

Primary

MeasureTime frame
Quality of life (SGRQ);MFI;

Secondary

MeasureTime frame
Activity ability (6-minute walking distance);HAMA& HAMD;Utilization rate of medical resources;

Countries

China

Contacts

Public ContactHongmei Zhao

China-Japan Friendship Hospital

lucy0500@163.com+86 13701135896

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026